| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8726f713a6d86892687edccfa03d886 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00 |
| filingDate |
2003-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1dec7bc2f01e5e4d9963cd52e7c78e6 |
| publicationDate |
2004-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004171085-A1 |
| titleOfInvention |
Methods and compositions for treating neurodegenerative diseases |
| abstract |
Methods and compositions for treating neurodegenerative diseases by modulating the interaction of ubiquitin to ubiquitin binding motifs are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009018029-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8677808-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007059312-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9488660-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8414774-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8410426-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010024527-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005123970-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012106313-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005130896-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010256010-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010237235-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7491501-B2 |
| priorityDate |
2002-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |